Gregory Siller
Central Brisbane Dermatology · Siller Medical T/A Central Brisbane Dermatology
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Gregory Siller as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:41 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04416516 · Safety and Efficacy of ASN-002 Combined With a Hedgehog Pathway InhibitorAscend Biopharmaceuticals Ltd · completed · Basal Cell Carcinoma, Basal Cell Nevus Syndrome · principal investigator
- Ph1/Ph2NCT02550678 · A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell CarcinomaAscend Biopharmaceuticals Ltd · completed · Basal Cell Nevus Syndrome, Skin Neoplasm, Nodular Basal Cell Carcinoma of Skin · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:41 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:41 UTC. The ranking covers the 200 most relevant of 7 PubMed records, and a shared surname and initials can bring in a namesake. All 7 on PubMed
- PEP005 (ingenol mebutate) gel, a novel agent for the treatment of actinic keratosis: results of a randomized, double-blind, vehicle-controlled, multicentre, phase IIa study.Australas J Dermatol · 2009101 citationsRCR 3.2
- PEP005 (ingenol mebutate) gel for the topical treatment of superficial basal cell carcinoma: results of a randomized phase IIa trial.Australas J Dermatol · 201093 citationsRCR 3.1
- Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies.Int J Dermatol · 200958 citationsRCR 2.2
- An open-label, pilot study examining the efficacy of curettage followed by imiquimod 5% cream for the treatment of primary nodular basal cell carcinoma.Australas J Dermatol · 200620 citationsRCR 0.8
- Timing of prophylactic antibiotics in abdominal surgery: trial of a pre-operative versus an intra-operative first dose.Br J Surg · 198917 citationsRCR 1.4
- 14 citationsRCR 0.6
- Chemoprevention of cutaneous squamous cell carcinoma and its precursors in solid organ transplant recipients using topical sirolimus: A randomized, double-blind, placebo-controlled pilot trial.J Am Acad Dermatol · 202211 citationsRCR 1.2